|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Klebsiella pneumoniae and Klebsiella oxytoca are the two most frequently encountered Klebsiella species giving rise to infections in humans. Klebsiella spp. causes urinary tract infections, ventilator-acquired pneumonias and blood stream infections (sepsis) among other conditions and is proving to be fatal. Klebsiella spp. has been associated with various types of infections and recently one of the most important and alarming aspects of Klebsiella spp. is the emergence of multi-drug resistant strains particularly those involved in nosocomial infection. Bacteria producing Klebsiella carbapenemases and extended-spectrum β-lactamases(ESBL), are rapidly emerging as a cause of multidrug-resistant infections worldwide. Bacterial isolates harbouring these enzymes are capable of hydrolysing a broad spectrum of β-lactams including the penicillins, cephalosporins, carbapenems and monobactam. Several cases which are almost resistant to all the antibiotic compel us to study its pattern. About hundred clinical isolates were collected from different wards, Icu, Nicu, Picu, postoperative wards of Tertiary care hospital of Jhalawar district. Out of which fifty two confirmed sample of Klebsiella spp.were further tested for antimicrobial drug susceptibility. The study is done in period of seven month from sep.2015 to march 2016.